ESTEMIQ Trademark

Trademark Overview

On Thursday, June 30, 2016, a trademark application was filed for ESTEMIQ with the United States Patent and Trademark Office. The USPTO has given the ESTEMIQ trademark a serial number of 87089558. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 22, 2020. This trademark is owned by Wyeth LLC. The ESTEMIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
estemiq

General Information

Serial Number87089558
Word MarkESTEMIQ
Filing DateThursday, June 30, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 22, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 5, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWyeth LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017
Party NameWyeth LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, June 22, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 22, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 12, 2019EXTENSION 5 GRANTED
Wednesday, November 6, 2019EXTENSION 5 FILED
Tuesday, November 12, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 6, 2019TEAS EXTENSION RECEIVED
Thursday, October 24, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 8, 2019EXTENSION 4 GRANTED
Monday, April 8, 2019EXTENSION 4 FILED
Monday, April 8, 2019TEAS EXTENSION RECEIVED
Saturday, October 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 11, 2018EXTENSION 3 GRANTED
Thursday, October 11, 2018EXTENSION 3 FILED
Thursday, October 11, 2018TEAS EXTENSION RECEIVED
Wednesday, April 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 23, 2018EXTENSION 2 GRANTED
Monday, April 23, 2018EXTENSION 2 FILED
Monday, April 23, 2018TEAS EXTENSION RECEIVED
Thursday, October 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 10, 2017EXTENSION 1 GRANTED
Tuesday, October 10, 2017EXTENSION 1 FILED
Tuesday, October 10, 2017TEAS EXTENSION RECEIVED
Tuesday, May 16, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 5, 2017ASSIGNED TO EXAMINER
Tuesday, March 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 13, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 26, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 6, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 6, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 15, 2016ASSIGNED TO LIE
Thursday, December 1, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, July 23, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, July 23, 2016NON-FINAL ACTION E-MAILED
Saturday, July 23, 2016NON-FINAL ACTION WRITTEN
Tuesday, July 19, 2016ASSIGNED TO EXAMINER
Tuesday, July 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 4, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

estemiq preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases